Results 41 to 50 of about 42,297 (231)

Antinuclear human autoantibodies as markers in Nicotiana tabacum pollen tubes

Acta Societatis Botanicorum Poloniae, 2014
In the present paper we report on the use of antinuclear human autoantibodies as specific markers in Nicotiana tabacum pollen tubes. The antibodies have been tested by fluorescence techniques using a confocal laser scanning microscope. All the antibodies
C. Poggialini, G. Morozzi, R. Marcolongo, R. Vignani, M. Cresti, A. Tiezzi   +5 more
doaj   +1 more source

Agreement of three commercial anti-extractable nuclear antigen tests: EUROASSAY Anti-ENA Profile, Polycheck Autoimmune Test and FID Connective Profile [PDF]

Kosin Medical Journal, 2018
BackgroundDetection of antibodies to extractable nuclear antigens (ENAs) is needed for the diagnosis in systemic autoimmune diseases. In this study, we compared three reagents using line immunoblot assay (LIA) or multiplex bead immunoassay for detecting ...
Namhee Kim, In-Suk Kim, Chulhun L Chang, Hyung-Hoi Kim, Eun Yup Lee   +4 more
doaj   +1 more source

A Rare RIPK3 Variant Enhances Necroptosis and Promotes Inflammation in a Still Disease–Like Autoinflammatory Syndrome

Arthritis &Rheumatology, EarlyView.
Objective Still disease represents a prototypical polygenic systemic autoinflammatory disease, characterized by recurrent systemic inflammation and dysregulation of innate immunity. Despite extensive clinical characterization, familial clustering Still disease remains unreported.
Longfang Chen, Qihua Dai, Yu Xiao, Jialin Dai, Mengyan Wang, Yuning Ma, Yujie Shen, Zhimo Xu, Jianfen Meng, Xia Chen, Da Yi, Yue Sun, Hui Shi, Honglei Liu, Xiaobing Cheng, Yutong Su, Junna Ye, Huihui Chi, Zhuochao Zhou, Tingting Liu, Jialin Teng, Chengde Yang, Jinchao Jia, Qiongyi Hu   +23 more
wiley   +1 more source

Antinuclear antibodies in children with Wilson’s disease

Аллергология и Иммунология в Педиатрии
.
O. V. Kurbatova, A. A. Zhuzhula, S. V. Lapin, M. A. Snovskaya, D. I. Kozlova, S. V. Petrichuk, D. G. Kuptsova, D. A. Kuznetsova, G. B. Movsisyan, A. D. Komarova, T. V. Radygina, A. B. Guslev, I. V. Kholopova, E. L. Semikina, S. G. Makarova, A. S. Potapov, A. P. Fisenko   +16 more
doaj   +1 more source

Antinuclear antibodies in postinfectious smell loss - a pilot study [PDF]

Rhinology Online, 2019
Background: Numerous diseases are mediated by autoimmune mechanisms some of which have been shown to be associated with reduced olfactory function, e.g. systemic lupus erythematosus, Sjögren syndrome, psoriasis vulgaris.
U. Walliczek-Dworschak, A.M. Zimmermann, S. Poletti, T. Hummel   +3 more
doaj   +1 more source

The American College of Rheumatology Updated Recommended Methods for Development of Disease Classification and Response Criteria

Arthritis &Rheumatology, EarlyView.
Disease classification criteria and response criteria are important tools in the conduct of observational studies and clinical trials for rheumatic diseases. This paper updates methodologic guidance for classification and response criteria funded, developed and/or endorsed by the American College of Rheumatology (ACR), incorporating contemporary ...
Sindhu R. Johnson, Tuhina Neogi, Amy S. Turner, Jaime Guzman, Zahi Touma   +4 more
wiley   +1 more source

ANTINUCLEAR ANTIBODIES IN DRUG-FREE SCHIZOPHRENICS

Eurasian Journal of Medicine, 2019
The nature of the association between auto-immune phenomena and schizophrenia is not entirely clear. In an attempt to define the auto-immune status of patients with schizophrenia, sera of patients and healthy controls were tested for antinuclear ...
Nazan Aydın, Esin Aktaş, Arzu Yiğit, Nimet Yiğit   +3 more
doaj  

Cirrosis biliar primaria: patología subdiagnosticada. Reporte de caso

Revista Médica Hondureña
Introduction: Primary biliary cirrhosis is a chronic, cholestatic, autoimmune, and progressive liver disease that pre-dominantly affects women.
Delmy Saraí Castillo Álvarez, Alejandra María Sosa, Diana Magoe Meza   +2 more
doaj   +1 more source

Integrated Clinical and Proteomic Profiling of CD19 Chimeric Antigen Receptor T Cell Therapy in Progressive Systemic Sclerosis

Arthritis &Rheumatology, EarlyView.
Objective To characterize the clinical, immunologic, and proteomic changes associated with CD19 chimeric antigen receptor T cell therapy in patients with progressive systemic sclerosis (SSc). Methods Patients with progressive SSc received CD19 chimeric antigen receptor (CAR)‐T cell therapy and were observed longitudinally for safety, clinical efficacy,
Chenhan Jia, Wanyi Lin, Zhangyi Zhao, Fenglin Wu, Chaoyu Gu, Yuankai Sun, Zhe Ding, Chang Wei, Xinyu Li, Cuiwei Xie, Peng Xia, Zhen Xia, Xuesong Liu, Shaoying Yang, Chunyan Zhang, Hanlin Yin, Liangjing Lu   +16 more
wiley   +1 more source

Expert Perspectives: Defining and Managing Progressive Pulmonary Fibrosis in Systemic Sclerosis

Arthritis &Rheumatology, EarlyView.
Systemic sclerosis–associated interstitial lung disease (SSc‐ILD) is one of the leading causes of morbidity and mortality in SSc, affecting up to three‐quarters of patients. The disease course is highly heterogeneous, ranging from indolent, nonprogressive forms to rapidly progressive pulmonary fibrosis (PPF).
Devis Benfaremo, Dinesh Khanna, Corrado Campochiaro, Vincent Cottin, Fabrizio Luppi, Marco Matucci‐Cerinic, Gianluca Moroncini, Yannick Allanore   +7 more
wiley   +1 more source